An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness-Reference-Cited by-同舟云学术

An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness

Published:2017-03-03 Issue:17 Volume:8 Page:28008-28020
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rigolin Gian Matteo¹,Formigaro Luca¹,Cavallari Maurizio¹,Quaglia Francesca Maria¹,Lista Enrico¹,Urso Antonio¹,Guardalben Emanuele¹,Martinelli Sara¹,Saccenti Elena¹,Bassi Cristian²,Lupini Laura²,Bardi Maria Antonella¹,Volta Eleonora¹,Tammiso Elisa¹,Melandri Aurora¹,Negrini Massimo²,Cavazzini Francesco¹,Cuneo Antonio¹

Affiliation:

1. Hematology Section, Department of Medical Sciences, Azienda Ospedaliero-Universitaria, Arcispedale S. Anna, University of Ferrara, Italy

2. Department of Morphology, Surgery and Experimental Medicine, and “Laboratorio per le Tecnologie delle Terapie Avanzate” (LTTA), University of Ferrara, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy;Leukemia & Lymphoma;2023-09-08

2. BTK inhibitor selection for chronic lymphocytic leukemia: which drug for which patient?;Expert Review of Hematology;2022-05-04

3. Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors;Current Oncology;2021-07-01

4. Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders;American Journal of Clinical Pathology;2021-03-13

5. Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia;Haematologica;2020-05-15